APA (7th ed.) Citation

Xu, Q., Huang, X., Meng, Z., Li, Y., Zhong, R., Li, X., . . . Lan, H. (2022). Antiarrhythmic effects of vernakalant in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1. Journal of cardiovascular development and disease, 9(4), . https://doi.org/10.3390/jcdd9040112

Chicago Style (17th ed.) Citation

Xu, Qiang, et al. "Antiarrhythmic Effects of Vernakalant in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1." Journal of Cardiovascular Development and Disease 9, no. 4 (2022). https://doi.org/10.3390/jcdd9040112.

MLA (9th ed.) Citation

Xu, Qiang, et al. "Antiarrhythmic Effects of Vernakalant in Human-induced Pluripotent Stem Cell-derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1." Journal of Cardiovascular Development and Disease, vol. 9, no. 4, 2022, https://doi.org/10.3390/jcdd9040112.